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Abstract
Background: In India, the Revised National TB control programme (RNTCP) offers free diagnosis and treatment for
tuberculosis (TB), based on the Directly Observed Treatment Short course (DOTS) strategy. We conducted a qualitative
study to explore the experience and consequences of having TB on patients enrolled in DOTS and their caretakers in
Tumkur district, located in a southern state of India, Karnataka.
Methods: We conducted 33 in-depth interviews on a purposive sample of TB patients from three groups: (1) patients
who reached RNTCP directly on their own and took DOTS at RNTCP; (2) patients who were referred by private
practitioners (PPs) to RNTCP and took DOTS at RNTCP; and (3) patients diagnosed by RNTCP and took DOTS from
PPs. Data was analyzed using a thematic approach with the support of NVivo9.
Results: The study revealed that TB and DOTS have a large impact on patient’s lives, which is often extended to
the family and caretakers. The most vulnerable patients faced the most difficulty in accessing and completing
DOTS. The family was the main source of support during patient’s recovery. Patients residing in rural areas and,
taking DOTS from the government facilities had to overcome many barriers to adhere to the DOTS therapy, such
as long travelling distance to DOTS centers, inconvenient timings and unfavorable attitude of the RNTCP staff,
when compared to patients who took DOTS from PPs. Advantages of taking DOTS from PPs cited by the patients
were privacy, flexibility in timings, proximity and more immediate access to care. Patients and their family had to
cope with stigmatization and fear and financial hardships that surfaced from TB and DOTS. Young patients living
in urban areas were more worried about stigmatisation, than elderly patients living in rural areas. Patients who
were referred by PPs experienced more financial problems compared to those who reached RNTCP services directly.
Conclusion: Our study provided useful information about patient’s needs and expectations while taking DOTS. The
development of mechanisms within RNTCP towards patient centered care is needed to enable patients and caretakers
cope with disease condition and adhere to DOTS.
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Background
In India, Tuberculosis (TB) remains a major public health
problem and accounted for 24 % of the total 9 million
cases reported worldwide in 2013 [1]. Following the
World Health Organization (WHO) declaring TB as a
‘global emergency’ in 1993, the Government of India (GoI)
launched the Revised National TB Control Programme
(RNTCP) in 1997 based on WHO endorsed Directly Ob-
served Treatment Short course (DOTS) strategy. RNTCP
was expanded in a phased manner to achieve complete
population coverage by 2006, with an overarching object-
ive to detect at least 70 % of sputum positive pulmonary
TB cases and to achieve a cure rate of at least 85 % [2].
The programme follows a ‘passive case finding’ approach,
which assumes that people are able to recognize their
symptoms and seek health care. Patients can avail RNTCP
services either by directly accessing public health facilities
or by being referred by private practitioners (PPs).
RNTCP is implemented mainly through public sector
health facilities, which provide free diagnostic and treat-
ment services. However in India, for many TB patients,
the first point of contact for health care are PPs [3–6].
Recognizing this, the Government involved PPs through
WHO recommended PPM (Public Private Mix)-DOTS
strategy [7, 8]. This partnership enables PPs to refer pa-
tients to the RNTCP for either free diagnosis or treatment.
Thereafter, the patient can either continue treatment
within RNTCP or alternatively PPs themselves can pro-
vide DOTS.
Studies from India [9, 10] and elsewhere [11–14] have
shown that accessing care and adhering with the long
course of TB treatment is a complex phenomenon.
However, most of these studies used a quantitative ap-
proach without further in-depth exploration into the
“whys” of the issues. Few studies have used a qualitative
approach to explore patient’s experiences during the dif-
ferent phases of DOTS treatment [15–18] Moreover, in
India there are very few published qualitative studies
[19, 20] that have captured the experience of patients
and their caretakers in obtaining and completing DOTS.
WHO’s post 2015 TB strategy states “Integrated, pa-
tient centred care”, as one of the main component of the
strategy [21]. Studies which analysed the reasons for
non-adherence to TB treatment in RNTCP have con-
cluded that it stems in a poor match between patients’
and programme’s needs and priorities [22]. To fulfil the
aspiration of ‘patient centred care’, the programme man-
agers and policy makers will have to give due attention
to patient’s needs and expectations from the programme.
With this background, we conducted this study to ex-
plore the experience and consequences of having TB on
patients enrolled in DOTS and their caretakers in Tum-
kur district, located in a southern state of India, Karna-
taka. The study findings described in this paper are part
of a larger study, which investigated how patients navi-
gate through the health system and gain access to
RNTCP and the organisational and operational chal-
lenges encountered in establishing collaboration between
PPs and the RNTCP in Karnataka state.
Methods
Study design
Qualitative research using in-depth interviews as data
collection tool.
Setting
The study was conducted in Tumkur district (total
population 2.716.997), Karnataka state, South India. The
district is spread over 10,597 square kilometers, with a
population density of about 253 persons per square kilo-
meter. Like elsewhere in India, the district has a pluralis-
tic health system composed of private and public health
facilities. As per the RNTCP guidelines, Tumkur dis-
trict is divided into six TB units, each catering to a
population of 500,000 and responsible for program im-
plementation. Under each TB unit, Designated Micros-
copy Centers (DMCs) provide free sputum microscopy
services, each catering to a population of 100,000.
Laboratory registers maintained at DMCs capture pa-
tient’s information such as name, age, sex, address,
source of referral, date of sputum examination, and
date of initiation of the TB treatment under the
RNTCP. The district has 2,555 DOTS centers that pro-
vide free TB drugs and try to ensure treatment comple-
tion. The DOTS provider is an observer other than a
family member, who supervises and supports the pa-
tients in taking their drugs at right doses and intervals.
The DOTS provider can be either a public health facil-
ity (all of them provide DOTS), a PP, a health worker or
any trained community volunteer who is acceptable and
accessible to patients and accountable to the health sys-
tem. If the patient resides far from the health facility,
DOTS provision is made closer to the patient’s residence
through a community health volunteer or a health worker.
Recruitment of study participants
We conducted a total of 33 in-depth interviews on a
purposive sample of new TB patients. Patients were re-
cruited from three different groups that were defined for
the purposes of the larger study mentioned above: (1)
patients who reached RNTCP directly on their own and
took DOTS at RNTCP; (2) patients who were referred
by PPs to RNTCP and took DOTS at RNTCP; and (3)
patients who were diagnosed by RNTCP and took
DOTS from PPs, irrespective of how they initially
reached RNTCP. Patients were further stratified for rural
(n = 18) and urban (15) settings.
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We aimed to interview eight respondents from each
category. Patients were shortlisted from RNTCP labora-
tory registers. Patient characteristics such as, whether
they reached RNTCP directly or were referred by a PP
or taking DOTS from a PP, duration of the treatment,
etc., were cross-checked with RNTCP TB registers and
treatment cards. To reduce the recall bias, we selected
patients who had completed their treatment in the last
three months or who were about to complete the treat-
ment in the next one month at the time of the interview.
Although we targeted eight respondents in each cat-
egory, we interviewed more respondents in the category
of ‘referred by PPs’ (n = 17). This is because, in the
course of data collection we discovered that some pa-
tients who were categorized as ‘having reached RNTCP
directly’ had initially consulted PPs for their illness and
were referred by them to the RNTCP.
Of the 33 interviews, 23 participants chose to be inter-
viewed at their residence. Caretakers were present in 21
of these interviews, and helped patients reconstruct their
experiences of care seeking. Of the 47 shortlisted pa-
tients, 14 patients could not be interviewed, 10 refused
to be interviewed, and four had shifted their place.
Data collection
Data was collected from May 2013 to August 2013.
Three interviews guides, one for each category of pa-
tients (see Additional files 1,2, and 3), were pilot-tested
in February 2013 and fine-tuned accordingly. In order to
elicit quality data, interviews were preceded by warm up
visits to interviewees by a field coordinator, who shared
the information brochure and explained about the re-
search project in the local language, Kannada. Efforts
were made to build rapport with patients and an ap-
pointment was sought for interviews. Participants were
given the choice to choose a date, time and place which
was convenient for them. The Principal Investigator (PI)
conducted the in-depth interviews in local language
Kannada, which lasted between 45 min to one and half
an hour. The main themes that were explored in the in-
terviews were effects and consequences of having TB
on individual and caregivers, and their experiences of
completing DOTS therapy in RNTCP.
Data analysis
A preliminary data analysis was conducted simultaneously
with data collection. All interviews were audio recorded
and transcribed verbatim by professional transcribers.
Each transcription was then crosschecked by the principal
investigator for accuracy and to include non-verbal com-
munication. We combined deductive and inductive ap-
proaches to analyse the data. The deductive approach was
based on the research questions and themes related to the
experience of TB patients and their caretakers with the
organizational and technical aspects of the delivery of
DOTS, that were contained in the interview guide (e.g.
previous and present experience with TB and DOTS, cost
of the treatment, provider related issues, side effects).
However, we kept the flexibility of including new themes
emerging from the data (inductive approach).
We conducted a thematic analysis [23, 24]. A coding
scheme was developed and refined progressively over
time (Fig. 1). Segments of the transcripts were classified
in the deductive themes. Simultaneously, themes that
emerged through scrutinizing the data (inductive) were
added. We systematically checked across the transcripts
for the consistency of these emerging categories. In later
stages of the analysis we explored the relationships be-
tween the themes and across different categories of par-
ticipants to identify patterns in the data. The analysis
was conducted with the support of QSR NVivo 9 (QSR
International Pvt LTD, Melbourne, Australia).
To increase the internal validity of the analysis, the cod-
ing scheme (Fig. 1) was regularly discussed with a sociolo-
gist (PL) not involved in data collection and other members
of the research team composed of researchers from differ-
ent backgrounds (e.g. epidemiology, public health).
Ethics
The study proposal received approval from the Institu-
tional Ethics Committee of the Institute of Public
Health, Bangalore and the Institutional Review Board of
the Institute of Tropical Medicine, Antwerp and Insti-
tutional Ethics Committee of Antwerp University. To
avoid any breach in medical confidentiality, the PI after
line listing the potential TB patients, shared the list
with the district TB officer, who in turn contacted field
RNTCP staff to check with patients if they agreed to be
interviewed. Following which, RNTCP staff contacted
patients over phone and informed them about the in-
terviews. RNTCP staff provided contact details of pa-
tients who agreed to participate and helped the PI
locate patients using local maps. After explaining the
confidentiality and nature of the research project in
local language, written informed consent was obtained
from all the participants by the PI for their participa-
tion in the research. Authorization for audio recording
the interviews was also sought. Personal details of the
participants were removed from the transcripts to en-
sure confidentiality and the audio files were anon-
ymised. The NVivo database was password protected
and was only accessible to the research team.
Results
Our results are presented as follows: after summarising
the characteristics of the patients, we describe the ex-
perience and consequences of having TB on patients en-
rolled in DOTS and their caretakers.
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Fig. 1 Coding Tree
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Participant characteristics
The average age of participants was 40 with the youngest
being 16 and the eldest 70. They were balanced for gen-
der. Income per month ranged from USD 62 to USD
314. Of the 33 patients, three patients had extra pul-
monary TB. All patients were new TB cases, except one
and none of them took treatment for multidrug resistant
TB. We are unable to provide a table of patient charac-
teristics as the table could lead to conflict in protecting
patients’ anonymity and confidentiality.
Experience and consequences of having TB on patients
enrolled in DOTS and their caretakers
As explained above, the recruited participants had recently
completed their treatment or were by the end of it. There-
fore, the experience of the patients with TB and their care-
takers is indissolubly linked to their experience with DOTS.
We observed that having TB was not solely an individ-
ual patient problem, but in most cases a family issue.
Some patients were found more vulnerable than others,
because of the relative level of poverty and social sup-
port they possessed. Patients who were referred by PPs,
patients belonging to lower Hindu caste, and patients
with low and middle-income status, tend to speak more
about their experiences. This is probably because they
had to overcome more barriers to access and complete
the DOTS treatment compared to the patients from
higher Hindu caste and residing in urban areas.
Our data revealed that the most challenging issues for
patients and their caretakers were related to coping with
DOTS strategy itself. These challenges can be grouped
in two broad categories: 1) organizational and technical
aspects of the delivery of the service; and 2) socioeco-
nomic and cultural implications of having a TB patient in
the family. The latest encompasses issues that emerged
through inductively analysing the data.
Organisational and technical aspects of the delivery of DOTS
Most of the respondents knew about the importance of
completing the treatment and the need for regular
follow-ups. They mentioned that the treatment was free
under RNTCP and that they had to reach DOTS cen-
tres to swallow tablets on alternate days (i.e. Monday,
Wednesday and Friday).
DOTS centres open only between 9 am to 1 pm, and pa-
tients and their caretakers had to make adjustments in
their daily routines to reach the health facility. For in-
stance, a family that lived on selling vegetables in the mar-
ket found it difficult to continue their business, as they had
to accompany their mother to a DOTS centre. Hence, they
sacrificed certain profit by giving away the vegetables to
middlemen in the market. A patient’s wife who was work-
ing as a sweeper in a theatre was the sole bread earner of
the family and she struggled to take care of her husband
and simultaneously attend her work. She explains: “In the
theatre I worked from morning 11.30 to 12.30 and then
took my husband to the hospital by afternoon at 1’o clock
to swallow tablets. Again from there we would start and
reach home by 4.30. And again by 5’o clock, I used to rush
to the theatre to work. Like this I managed” [wife of patient
who directly reached, M, R, 48 years].
Another concern highlighted by some patients was the
need to arrange DOTS closer to the patient’s residence.
Some patients, particularly the daily wage workers, had
to forfeit their wages to reach the DOTS centre. Thus,
they were left with a choice either to earn their liveli-
hood or to take DOTS therapy. Patients, who were se-
verely weak, who did not have stamina to walk to the
DOTS centres and could not afford auto fare to com-
mute to DOTS centre, were adversely affected.
Patients repeatedly expressed that DOTS should be
made flexible. In one case a mother, who herself was a
DOTS provider was not allowed to give DOTS to her
own daughter, who suffered from TB. That particular pa-
tient was told by RNTCP staff to visit the hospital, which
was 1.5 km away to take the DOTS. The family wanted
to hide the disease status from neighbours, as the patient
was not married and as they were anxious that suffering
from TB could become a threat to a future marriage.
The mother expressed her disappointment and was hurt
by RNTCP staff ’s apathy: “I pleaded them saying “please
give it [TB drugs] to me. But they did not give. I felt very
bad madam. I have given DOTS to so many patients”
[Mother of directly reached patient, F, R, 19 years].
Another patient cautioned, if the programme fails to
provide the flexibility in DOTS, patients might quit
treatment in the middle. An excerpt: “for people who do
daily wage work or go to garment industry, if they reach
the workplace late by even 15 min, they will be asked
many questions. Will they [owner] consider that they
[patients] had been to take the medicines? No… they will
be straightaway sent back home. For a patient, his work
is more important than the tablet and if the authorities
refuse to oblige, he will quit the tablets and proceed for
his work” [PP referred, M, U, 32 years].
Patients highlighted the need for improving the attitude
of RNTCP staff. They suggested that the program staff
should proactively know patient’s job profile and prioritise
those patients who go for work while giving DOTS. This
would enable patients to go back to their work after tak-
ing tablets. One patient narrated: “He [another patient
who came to take DOTS] is only 35 years old and has
two small children. He comes to TB hospital by morning
9.30 and by the time he reaches his house it will be
afternoon 2’o clock. He will not have any time to go to
work. He is in such a situation that if he does not go for
his treatment, he will die and if he does not go for work,
his children will die” [PP referred, M, U, 65 years].
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Almost all patients experienced severe vomiting and
giddiness in the initial stages of the treatment and also
expressed the need for patient counselling especially in
the initial stages of DOTS. Some patients were unhappy
that, RNTCP staff attitude was not good in such situa-
tions, when patients required the maximum support
from them. An excerpt: “If a patient gets vomiting sensa-
tion after taking tablets, TB centre staff should take care
of the patient. But these people just ask the patient to go
away and vomit. So, some patients because of vomiting
sensation associated with TB tablets don’t take the tab-
lets” [PP referred, M, U, 65 years].
Contrastingly, patients who took DOTS from PPs did
not face any such difficulties and all of them were satis-
fied with DOTS provided by PPs. All the eight patients
who received DOTS from PPs resided in urban areas.
The common reasons cited for taking DOTS from PPs
were the geographical proximity, and flexibility provided
by PPs in timings to take DOTS as per the patient’s
needs. Patients could consult PPs immediately when
they experienced some side effects of tablets. One pa-
tient who was a sales representative narrated how con-
venient it was to take DOTS from a PP: “Since I had to
leave to my job by 9.00 am, the doctor made arrange-
ments at my convenience. The nurse used to give me tab-
lets early in the morning and I used to take tablets and
leave for my job” [Taken DOT from PP, M, U, 50 years].
Female patients were particularly happy about the priv-
acy, which was provided at PP’s clinics while taking
DOTS. An excerpt; “I would have missed my college, if I
had to go in the morning to take tablets from TB hospital.
Moreover, there used to be so many people, there [TB hos-
pital]. I used to feel shy. Here [PP’s clinic] no one will be
there [she was shy while narrating this]. I used to feel com-
fortable here” [Taken DOT from PP, F, U, 18 years].
Only in two cases, the RNTCP staff took the initiative
to link them to the nearest PPs who provided DOTS. In
the remaining cases, patients had to negotiate with the
staff to look for a DOTS provider closer to their resi-
dence “I kept on telling them that it is difficult for me to
come here [TB hospital] every day. Then they said, we
cannot give drugs to home, but we can give it to a doctor
nearby my house. I told them to give tablets there [PP
clinic] and I took there for six months continuously”
[Taken DOTS from PP, M, U, 43 years].
Socioeconomic and cultural implications of having a TB
patient in the family
The main implications of having TB are fear and
stigmatization and an economical burden. Like any
disease TB has a cost for the patient. However, in-
ductively analysing our data we found that DOTS as
organized in India adds to these problems: the pa-
tient becomes visible to others and due to the long
duration of the treatment, the families are economic-
ally affected.
Patients had mixed feelings when they were diagnosed
with TB. They felt sad, shocked and afraid. Patients, es-
pecially those whose relatives had died of TB in the past
perceived TB as a big problem. About one third of pa-
tients felt that TB was not a dangerous disease and that,
if the treatment is taken regularly, it could be cured like
any other disease. Five of these patients had prior expos-
ure to TB patients who were cured.
Few patients were relieved when they were diagnosed
with TB, because they perceived initial symptoms such
as coughing blood as more serious or they were afraid to
be diagnosed with HIV or cancer. However, these results
should be interpreted with caution, because the percep-
tion of severity changed with time in some patients due
to (a) the counselling from doctors and paramedical staff
during the course of treatment (b) moral support pro-
vided by friends and relatives and (c) relief of symptoms
after starting the treatment.
We observed that almost all the respondents were un-
comfortable to use the word “TB”. Instead, they referred
to it as ‘illness’. Most patients did not share their disease
status with their relatives or neighbours for the fear of
getting excluded or getting bad comments. An excerpt:
“I did not want our neighbors to know about this. They
[TB staff] said, “we can give the tablets to Anganawadi
Centre [DOTS center] or somebody’s house near my resi-
dence”. We refused and said, we will not go anywhere
and we will come swallow tablets in the hospital itself”
[Directly reached, F, R, 19 years].
The tendency of hiding the disease was more among
younger patients. Contrastingly, elderly patients in the
rural areas tend to share their difficulties with neigh-
bours and there was a certain degree of social accept-
ance for these patients. We also observed that patients
who had social support in the rural areas were less wor-
ried about stigmatisation compared to those who did
not have. However, patients residing in urban areas
took utmost care not to reveal their disease status to
anybody, irrespective of the age group. In rural areas,
neighbours usually knew the disease status, as it was
difficult to hide from the neighbours as expressed by
one patient: “Normally village people will ask lot of
questions, whereas in cities no one will ask. When
people ask, we have to give reasons as to why we are vis-
iting the hospital daily. Otherwise they will keep asking
the same question another 20 times. A situation will
come, when we will have to tell everyone whoever asks”
[PP referred, F, R, 30 years].
Many patients experienced discrimination in one form
or the other. In many instances, patient’s relatives stood
far from them or did not allow children near them for
the fear of contracting the disease. Patients were hurt by
Yellappa et al. BMC Health Services Research  (2016) 16:283 Page 6 of 11
this discrimination. One patient explains, “when my rela-
tives used to come home to see me, they used to hesitate
to even drink water in my home” [PP referred, M, U,
41 years]. However, the same patient defends their be-
haviour, explaining that TB is a contagious disease and it
is quite normal for relatives to fear about it and behave
in such a manner. “It is just similar to situations like, if
we have dengue in our surroundings, we tend to shut the
doors to get rid of the mosquitoes”.
Immediate family members were always informed
about the disease. In almost all cases, the family was the
main source of support during patient’s recovery. How-
ever, patients imposed certain behaviour on themselves
such as self-isolation, keeping their plates and cups sep-
arately, not allowing children to come close to them, etc.
This behaviour was mostly ‘self-induced’ because of the
fear of spreading the disease to family members and they
were extremely cautious about it. Most patients knew
that TB is contagious, and hence closed their mouth
while coughing to prevent the spread of the disease to
other family members. However, this fear came down
eventually when they saw many patients taking DOTS in
hospitals. These ‘self-induced’ behaviours were influ-
enced by previous exposure of patient’s parents and their
relatives to TB and also induced by health staff sugges-
tions. An excerpt:
“The doctor had informed that the disease would not
spread after two months. It will not have the strength.
Hence after two moths I went out of house to meet
friends” [PP Referred, Male (M), Urban (U), 32 years].
We observed that there was a strong belief among the
caretakers that TB patients should be isolated and be
provided with separate plates and bed covers. In two
cases, it was apparently advised by health staff. Many
caretakers believed washing patients clothes in hot water
will help in speedy recovery: “clothes should be washed
in hot water everyday. Then it will be cured fast” [Dir-
ectly reached, F, R, 41 years]. One patient was made to
stay in a separate house where cattle were kept and food
was served there till 4–5 months after the initiation of
treatment. That particular patient narrates how painful
this isolation was: “I was feeling very bad that I had to
stay away like this. I was thinking why I should live like
this, when nobody wants me. But day-by-day I was im-
proving and I was cured. I forgot about all those things”
[PP referred, M, R, 50 years].
Patients and their family struggled to meet the finan-
cial burden that surfaced due to TB. All patients suffered
from severe symptoms, which incapacitated their ability
to work, and found it difficult to earn their living. Major
expenditure was towards arranging nutritious food and
transportation costs to reach DOTS centre on alternate
day. Patients who could afford were mostly residing in
the urban areas. They travelled to the DOTS centre in a
motorcycle or an auto, mostly accompanied by a care-
taker. In India, each trip costs a minimum of Rs.60
[1USD], which is costly considering the fact that patients
were unable to earn income during the period. Patients
and caretakers from the rural areas took loans to meet
the additional expenses from relatives, friends, banks,
self-help groups, working place and pledge the jewellery
and house. In some instances, parents tried to earn extra
money working as maids to take care of their offspring
who suffered from TB. Ten patients had taken loans and
nine out of them were referred by PPs. They repented
on their decision to seek care from PPs instead of dir-
ectly reaching RNTCP services. Many were still repaying
the loan at the time of the interview. An excerpt “If I
had gone to government hospital in the first instance it-
self, we would not have taken this much loan. We would
not have been a debtor. God knows when I will be able
to clear my loans” [PP referred, M, R, 50 years].
Patients who had severe symptoms were admitted to
the hospital and so found it hard to manage their busi-
ness or secure their job during hospitalisation. One pa-
tient, who worked as an electric supervisor, could not
stop working for the fear of losing his job. He left for his
work from the hospital without informing anybody, with
the intravenous cannula intact in his hand. He narrated:
“Even when I was admitted, I had removed the drips
[intra venous fluids] and went to work without the doc-
tor’s and family’s notice. If I did not go, then I would
have lost the job and I would not have survived” [PP re-
ferred, M, U, 41 years]
Another issue that increased the economic burden of
the families was the strong belief that existed among pa-
tients and caregivers that it was mandatory to eat non-
vegetarian food for speedy and complete recovery from
TB. Thus, patients spent substantial amounts of money
towards arranging non-vegetarian food. Caretakers on
the other hand, made efforts to cope up with extra fi-
nancial burden to meet this requirement. Villagers went
to town to buy fruits and some caregivers managed to
cook meat once in three days with lots of financial diffi-
culties and, in some instances neighbours shared mutton
dishes when they prepared. Hence, some respondents
suggested that the government should provide either ba-
nana or egg to the patients along with DOTS.
Two patients, who were Hindus, narrated the experi-
ence of eating beef in the anticipation of fast recovery
from TB. Eating beef is not allowed in Hindu religion
and these two respondents revealed this fact only to-
wards the end of interview with lot of hesitation. Since
beef could not be cooked at home, they had to go in
search of hotels to eat beef. Every beef meal costed them
USD 2–3. They firmly believed that eating beef helped
them in fast recovery and rapid weight gain. They took
utmost care not to reveal it to anybody, including the
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family members. “If we eat fish and beef along with tab-
lets properly, we will get cured fast. Only mere tablets
and eating the usual food prepared at home will not cure
TB” [PP referred, M, U, 41 years].
None of the interviewed patients paid money to avail
RNTCP services in the Government hospitals except few
who had purchased streptomycin injection from private
pharmacies, due to the stock out in government facil-
ities. Almost all the participants expressed gratitude to-
wards government for delivering them free medications,
but also suggested that the Government should provide
financial assistance to the poor patients who could not
earn their livelihood while taking DOTS. Some sug-
gested provision of free shelter and food in the initial
two months of the treatment for severely ill, and poor
patients, with no social support.
Discussion
This qualitative study has revealed that TB and DOTS
have a large impact on patient’s lives, which is often ex-
tended to the family and caretakers. The patients who
faced the most difficulty in accessing and completing
DOTS were the ones who were most vulnerable to the
disease because of the relative level of poverty and social
support they possessed. In all cases, the family was the
main source of support during patient’s recovery. Patients
residing in rural areas, taking DOTS from the government
hospitals had to overcome many barriers to adhere to the
DOTS therapy, such as long travelling distance to DOTS
centers, inconvenient timings and unfavorable attitude of
the RNTCP staff, when compared to patients who took
DOTS from PPs in urban area. Patients identified advan-
tages of taking DOTS from PPs such as privacy, flexibility
in timings, proximity and more immediate access to care.
Patients and their family had to cope with stigmatization
and fear and financial hardships that surfaced from TB
and DOTS. Patients who were referred by PPs experi-
enced more financial struggle compared to those who
reached RNTCP services directly.
Qualitative findings are not generalizable outside study
settings. However, our findings are most probably trans-
ferable to similar settings in India. Though we took steps
to reduce recall bias during participant’s recruitment, it
could not be ruled out completely. The results described
in the present study are solely based on patient’s and
caregiver’s experience and reconstruction of the events
that occurred during the treatment of the illness. It
could have been useful to complement this information
with the perspective of health care providers. Patients
were identified from the RNTCP registers and were ini-
tially contacted by RNTCP staff over phone to partici-
pate in the study. Hence, some respondents could have
not wanted to share information regarding program staff
that could have jeopardized their relationship with them.
Lienhardt and Ogden have argued that strict and univer-
sal application of DOTS can decrease the effectiveness of
TB control [25]. Our respondents also expressed concerns
for introducing more flexibility in the DOT and suggested
to improve the attitude of DOTS providers as reported in
other studies [26]. In their study Pranaya Mishra et al. [27]
concluded that poor communication between patients
and DOTS providers were significantly associated with
non-adherence. Our results and the above studies call for
strengthening the competences of the health personnel in-
volved in TB care and to improve communication through
appropriate training.
In our study, we observed that, patients who took
DOTS from PPs were satisfied with the flexibility of the
service and the care provided by them. This supports a
study finding that patients who took TB treatment out-
side RNTCP perceived DOTS, as applied in India, to be
rigid and intrusive [28]. As mentioned in the back-
ground, the majority of TB patients in India seek care
from PPs. Hence, every effort to control TB should
prioritize the ways to engage with PPs optimally, includ-
ing the provision of DOTS. In our study, it was found
that the programme took the initiative to link only two
patients with PPs for DOTS provision. This indicates the
need to involve more PPs optimally in the delivery of
DOTS, regardless of whether patients seek care in the
public or the private sector.
There has been an extensive debate around DOTS ver-
sus Self-Administered Therapy (SAT) for TB patients.
Results of two randomized control trials have shown
that there was little to be gained by DOTS compared
with SAT [29, 30]. A recent study from India also con-
cluded that there was no significant difference between
success rate in patients taking DOTS and SAT [31].
Similar findings were obtained in an integrated review of
DOTS conducted in Latin-America [32]. Some alterna-
tives for DOTS administration have been also studied
and promoted such as community-based DOTS. A sys-
tematic review recently conducted by Zhang and col-
leagues [33] on the impact of community-based DOTS
showed that this alternative has improved TB treatment
outcomes. Volminck and colleagues, in their systematic
review on DOTS for TB control concluded that health
care delivery oriented towards the needs and preferences
of patients seemed to lead to more satisfied patients
[34]. Studies have shown that introducing flexibility in
DOTS may indeed allow for more efficient [35, 36] and
cost effective [37]. Recently, there have been moves in
the international TB control landscape. WHO TB con-
trol, previously heavily based on DOTS [38] has shifted
to the STOP TB Partnership, that focuses on a patient-
centered approach to TB care taking into account the
needs, perspectives, and individual experiences of people
affected by TB [39].
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It is essential that programme managers recognise that
patients strive to adhere to their treatment, but struc-
tural barriers prevent them from doing so [40]. Our
study resonates largely with the social determinants
model of health which put emphasis on the social fac-
tors that could affect individuals’ ability to seek health
care and adhere to a course of treatment [41, 42]. Cur-
rently RNTCP is vertically oriented, with more emphasis
on programme targets than on the patients [43]. TB ad-
vocates have urged for a patient-centered solution to TB
control, delivered with dignity and compassion [44].
RNTCP may have to consider this as a priority, if its am-
bitious goal envisaged in its national strategic plan of
providing ‘universal access to quality assured free diag-
nosis and treatment to patients’, is to become a reality
[2]. Being responsive to the local context, meeting the
patient’s expectations and needs, and empower patients
with the help of the family and caretakers to complete
the treatment is a way forward [45, 46].
It was our consistent finding that patients always shared
their disease condition with their close family members.
We further observed that the adherence to treatment was
heavily dependent on patient's and caretaker’s competing
needs of everyday life. Similarly to other studies, social
support from spouse and close family members was cru-
cial in adhering to the DOTS therapy [47] and the more
the social support, the better the coping with the disease
condition [48]. Therefore, the TB programme needs to ac-
knowledge the crucial role of the families and proactively
involve them in patient counselling to increase their
knowledge and awareness about the disease. A better un-
derstanding of TB as a disease condition within the fam-
ilies may improve patient care.
The majority of the respondents did not share their
disease status with others, except the immediate family
members. A study which assessed the overall TB stigma
index in India, Bangladesh, Malawi and Colombia, re-
ported that it was highest in India [49]. Studies from
India and neighboring Pakistan reported that women
were concerned about rejection by their husbands, har-
assment by in-laws, and the reduced chances of marriage
because of TB [50–52] Similarly, we observed that
women respondents in our study were satisfied receiving
DOTS from PPs, as it provided them privacy. Patients
were discriminated and many of them self-isolated with
the fear that they will spread the disease to kith and kins,
a finding similar to a qualitative study from Nepal [53].
In our study we found that some field health workers
suggested self-isolation to some of the patients. This
calls for training of this staff. Overall, all these findings
point towards the stigma of TB in the Indian society and
the urgent need for the programme to reduce stigma re-
lated problems in the TB care and control efforts, by
conducting effective awareness programs. However, it is
important to point out that the way DOTS is adminis-
tered in India increases the stigmatization of the disease
as shown by our findings.
Our study findings add to the evidence that TB patients
in India incur large costs associated with TB illness [54–
57]. TB had devastating socio-economic impact on our
study participants and their families, especially from rural
areas and further increased their poverty as reported in
other studies [58, 59]. This phenomenon typically illus-
trates the ‘medical poverty trap’, a situation where expend-
iture increases and income decreases [60]. We found that
arranging for ‘nutritious’ food during the course of the
treatment created a significant financial burden, a finding
similar to a study from Zambia which reported on sub-
stantive ‘special food’ expenditures [61].
Our study findings are also in line with the widely recog-
nized phenomenon of ‘inverse care law’, which explains that
those who are in most need of healthcare are least able to ac-
cess services [62]. Because of long distance and inconvenient
timings of DOTS centers, patients had to struggle to reach
them on time. Studies have shown that long distance from
DOTS centre, having an occupation or other socio-cultural
obligations are some of the reasons for patients to discon-
tinue TB treatment [47, 48]. Another study, which analyzed
the factors affecting compliance of patients with DOTS, re-
ported that it is affected by travel expenses and the amount
of time that patients must spend travelling to treatment cen-
tres. Cost of transport was the reason most frequently given
for non-compliance [63]. For improving TB control several
authors have stressed that provision of DOTS is insufficient
and called for introducing pro poor, equity enhancing mea-
sures to address poverty in TB control efforts [64–66]. Initia-
tives of systematically including TB patients under social
protection schemes may prove beneficial in this regard [67].
Conclusion
Our study provides useful information about patient’s needs
and expectations regarding the delivery of DOTS in India.
We also have flagged the need for developing mechanisms
within RNTCP to help patients and their families to cope
up with disease condition. The programme should make a
paradigm shift, to move to a more patient centred approach.
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